Upcoming biocomputing conferences
Computational modeling can help fill gaps in how we develop and review new drugs and devices
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
From cellular responses to drugs, to adverse effects and drug repositioning, systems pharmacology gets the BD2K treatment
Cardiovascular models are moving to the bedside
i2b2 enables the use of existing clinical data for discovery research
Computers and human experts duke it out over who is better at diagnosing disease, interpreting images, or predicting protein structure
Bringing models closer to reality
Computation can speed up the time it takes to find new binding partners for old drugs
Computation offers a window into a disease often described as a black box
- 1 of 3
- ››